1. What We Do

AR Provincial Maternal-Child Health Investment APL 2

Abstract*

The Provincial Maternal-Child Health Investment Project for Argentina will: (i) increase access for uninsured others and children to basic health services known to effectively address the main causes of maternal and under-5 mortality in 15 provinces of Argentina; (ii) strengthen the incentive framework for efficiency and focus on results between the national level and the participating provinces and among provinces and service providers. Components...

* The project abstract is drawn from the PAD, SAR or PGD and may not accurately reflect the project's current nature

Show More

Development Objective

The project development objectives are: (a) to increase access by eligible uninsured mothers and children to basic health services; (b) to strengthen the incentive framework for efficiency and focus on results between the national level and the Eligible Provinces and among Eligible Provinces and service providers by linking financing to both services actually rendered to the target populationand to the achievement of the MCHIP results as reflected by the selected ten tracers of the Trazadoras Matrix.

Key Details

Project Details

  • P095515

  • Closed

  • Andrew Rajkumar

  • N/A

  • Argentina

  • July 11, 2006

  • (as of board presentation)

    November 2, 2006

  • May 31, 2007

  • US$ 300.00 million

  • C

  • May 9, 2013

  • December 31, 2012

  • BANK APPROVED

  • Notes

Sectors

Created with Highstock 5.0.14FY17 - Central Government(Central Agencies)FY17 - Central Government (Central Agencies)FY17 - Sub-National GovernmentFY17 - Public Administration -HealthFY17 - Public Administration - HealthFY17 - Health

Themes

Project Map

Interactive Map

Finances

Financing Plan (US$ Millions)

No data available.
Financier Commitments
International Bank for Reconstruction and Development 300.00

Total Project Financing (US$ Millions)

Product Line IBRD/IDA
IBRD Commitment 300.00
IDA Commitment N/A
IBRD + IDA Commitment 300.00
Lending Instrument
Grant Amount N/A
Total Project Cost** 300.00

Summary Status of World Bank Financing (US$ Millions) as of March 31, 2025

Download:
No data available.
Financier Approval Date Closing Date Principal Disbursed Repayments Interest, Charges & Fees

Detailed Financial Activity as of March 31, 2025

Download:
No data available.
Period Financier Transaction Type Amount (US$)
Jan 1, 2014 IBRD-74090 Loan Repay 3,398,266.80
Jan 1, 2014 IBRD-74090 Loan Repay 8,124,990.50
Jan 1, 2014 IBRD-74090 Loan Repay 2,483,255.80
Jul 1, 2013 IBRD-74090 Int Charges 1,169,853.40
Jul 1, 2013 IBRD-74090 Int Charges 1,388,646.10
Jul 1, 2013 IBRD-74090 Loan Repay 1,374,201.20
Jul 1, 2013 IBRD-74090 Loan Repay 3,398,266.80
Jul 1, 2013 IBRD-74090 Int Charges 1,083.95
Jul 1, 2013 IBRD-74090 Int Charges 89,222.68
Jul 1, 2013 IBRD-74090 Int Charges 363.09
Jul 1, 2013 IBRD-74090 Loan Repay 10,608,246.00
Jul 1, 2017 IBRD-74090 Int Charges 619,334.20
Jul 1, 2017 IBRD-74090 Loan Repay 1,452,048.40
Jul 1, 2017 IBRD-74090 Int Charges 735,178.20
Jul 1, 2017 IBRD-74090 Loan Repay 1,374,201.20
Jul 1, 2017 IBRD-74090 Loan Repay 3,398,266.80
Jul 1, 2017 IBRD-74090 Loan Repay 9,156,198.00
Jan 1, 2017 IBRD-74090 Loan Repay 1,374,201.20
Jan 1, 2017 IBRD-74090 Loan Repay 3,398,266.80
Jan 1, 2017 IBRD-74090 Int Charges 81,406.72
Jan 1, 2017 IBRD-74090 Int Charges 688,149.06
Jan 1, 2019 IBRD-74090 Loan Repay 1,374,201.20
Jan 1, 2019 IBRD-74090 Loan Repay 3,398,266.80
Jan 1, 2019 IBRD-74090 Loan Repay 9,589,500.00
Jan 1, 2019 IBRD-74090 Loan Repay 1,018,746.56
Jul 1, 2018 IBRD-74090 Int Charges 481,704.30
Jul 1, 2018 IBRD-74090 Int Charges 100,960.52
Jul 1, 2018 IBRD-74090 Loan Repay 3,398,266.80
Jul 1, 2018 IBRD-74090 Int Charges 571,811.25
Jul 1, 2018 IBRD-74090 Loan Repay 1,374,201.20
Jul 1, 2018 IBRD-74090 Loan Repay 10,608,246.00
Jan 1, 2018 IBRD-74090 Loan Repay 1,374,201.20
Jan 1, 2018 IBRD-74090 Loan Repay 3,398,266.80
Jan 1, 2018 IBRD-74090 Loan Repay 10,608,246.00
Jan 1, 2018 IBRD-74090 Int Charges 0.01
Jan 1, 2018 IBRD-74090 Int Charges 95,422.35
Jan 1, 2018 IBRD-74090 Int Charges 550,519.20
Jan 1, 2018 IBRD-74090 Int Charges 653,494.75
Jan 1, 2018 IBRD-74090 Int Charges -0.01
Jul 1, 2019 IBRD-74090 Loan Repay 1,374,201.20
Jul 1, 2019 IBRD-74090 Loan Repay 3,398,266.80
Jul 1, 2019 IBRD-74090 Loan Repay 10,608,246.00
Jul 1, 2019 IBRD-74090 Int Charges 107,602.91
Jul 1, 2019 IBRD-74090 Int Charges 344,074.50
Jul 1, 2019 IBRD-74090 Int Charges 408,444.20
Jan 1, 2019 IBRD-74090 Int Charges 115,729.42
Jan 1, 2019 IBRD-74090 Int Charges 412,889.47
Jan 1, 2019 IBRD-74090 Int Charges 490,127.70
Jul 1, 2020 IBRD-74090 Loan Repay 10,111,831.00
Jul 1, 2020 IBRD-74090 Loan Repay 496,415.25
Jul 1, 2020 IBRD-74090 Int Charges 44,893.34
Jul 1, 2020 IBRD-74090 Int Charges 206,444.70
Jul 1, 2020 IBRD-74090 Int Charges 245,077.20
Jul 1, 2020 IBRD-74090 Loan Repay 1,374,201.20
Jul 1, 2020 IBRD-74090 Loan Repay 3,398,266.80
Jan 1, 2020 IBRD-74090 Loan Repay 9,937,257.00
Jan 1, 2020 IBRD-74090 Loan Repay 670,988.94
Jan 1, 2020 IBRD-74090 Int Charges 275,259.60
Jan 1, 2020 IBRD-74090 Int Charges 326,760.72
Jan 1, 2020 IBRD-74090 Loan Repay 1,374,201.20
Jan 1, 2020 IBRD-74090 Loan Repay 3,398,266.80
Jan 1, 2020 IBRD-74090 Int Charges 68,968.62
Jul 1, 2021 IBRD-74090 Int Charges 3,494.22
Jan 1, 2021 IBRD-74090 Loan Repay 3,398,266.80
Jan 1, 2021 IBRD-74090 Loan Repay 8,672.94
Jan 1, 2021 IBRD-74090 Int Charges 8,672.94
Jan 1, 2021 IBRD-74090 Int Charges 163,393.69
Jan 1, 2021 IBRD-74090 Loan Repay 163,393.69
Jan 1, 2021 IBRD-74090 Loan Repay 8,672.94
Jan 1, 2021 IBRD-74090 Loan Repay 3,398,266.80
Jan 1, 2021 IBRD-74090 Loan Repay 7,201,306.50
Jan 1, 2021 IBRD-74090 Int Charges 128,956.92
Jan 1, 2021 IBRD-74090 Int Charges 8,672.94
Jan 1, 2021 IBRD-74090 Loan Repay 1,202,134.60
Jul 1, 2021 IBRD-74090 Loan Repay 81,710.22
Jul 1, 2021 IBRD-74090 Loan Repay 3,398,267.00
Jul 1, 2021 IBRD-74090 Loan Repay 3,398,267.00
Jul 1, 2021 IBRD-74090 Loan Repay 5,696,722.50
Jul 1, 2021 IBRD-74090 Loan Repay 68,814.90
Jul 1, 2021 IBRD-74090 Loan Repay 3,494.22
Jul 1, 2021 IBRD-74090 Loan Repay 1,362,708.00
Jul 1, 2021 IBRD-74090 Int Charges 68,814.90
Jul 1, 2021 IBRD-74090 Int Charges 81,710.22
Jul 1, 2021 IBRD-74090 Loan Repay 1,362,708.00
Nov 2, 2006 IBRD-74090 Loan Commitment 300,000,000.00
Jan 1, 2014 IBRD-74090 Int Charges 75,254.64
Jan 1, 2014 IBRD-74090 Int Charges 1,101,038.40
Jan 1, 2014 IBRD-74090 Int Charges 1,306,962.80
Jan 1, 2014 IBRD-74090 Loan Repay 1,374,201.20
Jan 1, 2015 IBRD-74090 Int Charges 56,998.34
Jan 1, 2015 IBRD-74090 Int Charges 963,408.70
Jan 1, 2015 IBRD-74090 Int Charges 1,143,595.60
Jan 1, 2015 IBRD-74090 Loan Repay 1,374,201.20
Jan 1, 2015 IBRD-74090 Loan Repay 3,398,266.80
Jan 1, 2015 IBRD-74090 Loan Repay 10,608,246.00
Jul 1, 2014 IBRD-74090 Int Charges 1,032,223.56
Jul 1, 2014 IBRD-74090 Int Charges 1,225,279.20
Jul 1, 2014 IBRD-74090 Loan Repay 1,374,201.20
Jul 1, 2014 IBRD-74090 Loan Repay 3,398,266.80
Jul 1, 2014 IBRD-74090 Loan Repay 10,608,246.00
Jul 1, 2014 IBRD-74090 Int Charges 62,147.94
Jan 1, 2016 IBRD-74090 Int Charges 58,115.64
Jan 1, 2016 IBRD-74090 Int Charges 825,778.80
Jan 1, 2016 IBRD-74090 Int Charges 980,228.70
Jan 1, 2016 IBRD-74090 Loan Repay 1,374,201.20
Jan 1, 2016 IBRD-74090 Loan Repay 3,398,266.80
Jan 1, 2016 IBRD-74090 Loan Repay 8,744,123.00
Jan 1, 2016 IBRD-74090 Loan Repay 1,864,123.10
Jul 1, 2015 IBRD-74090 Int Charges 54,754.55
Jul 1, 2015 IBRD-74090 Int Charges 894,593.75
Jul 1, 2015 IBRD-74090 Int Charges 1,061,912.10
Jul 1, 2015 IBRD-74090 Loan Repay 1,374,201.20
Jul 1, 2015 IBRD-74090 Loan Repay 3,398,266.80
Jul 1, 2015 IBRD-74090 Loan Repay 10,608,246.00
Jan 1, 2017 IBRD-74090 Int Charges 816,861.70
Jul 1, 2016 IBRD-74090 Int Charges 83,235.41
Jul 1, 2016 IBRD-74090 Int Charges 756,963.94
Jul 1, 2016 IBRD-74090 Int Charges 898,545.20
Jul 1, 2016 IBRD-74090 Loan Repay 1,374,201.20
Jul 1, 2016 IBRD-74090 Loan Repay 3,398,266.80
Jul 1, 2016 IBRD-74090 Loan Repay 8,869,502.00
Jul 1, 2016 IBRD-74090 Loan Repay 1,738,744.50
Jan 1, 2017 IBRD-74090 Loan Repay 10,608,246.00
Jul 1, 2017 IBRD-74090 Int Charges 97,535.99
Footnotes

Ratings

IMPLEMENTATION RATINGS

Name Review Date
Overall Safeguards Rating Satisfactory 2012-12-25
Counterpart Funding Moderately Satisfactory 2012-12-25
Project Management Satisfactory 2012-12-25
Monitoring and Evaluation Moderately Satisfactory 2012-12-25
Overall Implementation Progress (IP) Moderately Satisfactory 2012-12-25
Progress towards achievement of PDO Moderately Satisfactory 2012-12-25
Procurement Moderately Satisfactory 2012-12-25
Financial Management Moderately Satisfactory 2012-12-25
Overall Safeguards Rating Satisfactory 2012-12-25

COMPLETION RATINGS

INDICATORIMPLEMENTATION COMPLETION & RESULTS REPORT: 06-27-2013
Outcomes
Risk to Development OutcomeSubstantial
Bank Performance
Borrower Performance
Government Performance
Implementing Agency

INDEPENDENT EVALUATION RATINGS

INDICATORICR REVIEW: 07-23-2014PROJECT PERFORMANCE ASSESSMENT REPORT:
Outcome RatingSatisfactory N/a
Risk To Development OutcomeModerateN/a
Bank PerformanceModerately SatisfactoryN/a
Borrower PerformanceModerately SatisfactoryN/a
Government PerformanceModerately SatisfactoryN/a
Implementing AgencyModerately SatisfactoryN/a
Icr QualitySatisfactoryN/a
M&e QualityModestN/a

Results Framework

PROJECT DEVELOPMENT OBJECTIVE INDICATORS

INDICATORBASELINECURRENTTARGET
  • Proportion of eligible population voluntarily enrolled in the program in 15 provinces.Value0%Phase I: 96.9%Phase II: 95.8%80%
    DateAugust 30, 2006October 31, 2012December 31, 2012
    CommentThis indicator has been achieved and substantially surpassed, for both Phase I and II provinces.
  • Proportion of enrolled pregnant women who get VRDL during pregnancy and antitetanic vaccine previous to delivery.Value70%Phase I: 89.1%Phase II: 81.3%90%
    DateAugust 30, 2006August 31, 2012December 31, 2012
    CommentIndicator end target not yet achieved by August 31, 2012, but less than 1% from target for Phase I provinces (so high chance ofbeing achieved by project close for Phase I provinces).
  • Proportion of newborns from enrolled pregnant women weighing more than 2,500 g.Value70%Phase I: 90.6%Phase II: 90.2%85%
    DateAugust 30, 2006August 31, 2012December 31, 2012
    CommentIndicator end target achieved for both Phase I and II provinces.
  • Percentage of MSN-MSP annual performance agreements successfully implemented.Value0%Phase I: 88%Phase II: 73%At least 60% of all participant provinces at the e
    DateAugust 30, 2006October 31, 2012December 31, 2012
    CommentThis indicator's end target has been achieved, and substantially surpassed, in Phase I as well as Phase II provinces. Thedefinition of this indicator was changed recently. According to the previous definition, all annual performance agreements thathad been signed and were being implemented were counted, regardless of the quality of the implementation. Previous recent levels ofachievement were 100%, based on this previous definition. The values reported for this indicator in this ISR are based on thelatest definition agreed to with the Bank which is more stringent, that is one should only count performance agreements where: (i)the rate of enrolment of the eligible population is higher than the minimum target agreed to, and also: (ii) at least 70% of allprojects in the Strategic Plan of Technical Assistance and Capacity Building (which is a part of the performance agreement) havebeen executed.
  • Percentage of authorized providers under annual performance agreements and provider payment mechanism with its respective participant province.Value0%Phase I: 95%Phase II: 90%At least 50% of all authorized providers in each p
    DateAugust 30, 2006October 31, 2012December 31, 2012
    CommentThis indicator's end target has been achieved, and substantially surpassed, in Phase I as well as Phase II provinces.
  • Percentage of trazadora targets achieved by the participant provinces in last year billing period.Value0%Phase I: 93.3%Phase II: 88%At least 70% of all participant provinces at the e
    DateAugust 30, 2006August 31, 2012December 31, 2012
    CommentThis indicator's end target has been achieved and substantially surpassed for both Phase I and II provinces.
  • Proportion of eligible pregnant women with first antenatal care visit before week 20th of pregnancyValuen.aPhase I: 69.4%Phase II: 64.9%70%
    DateAugust 30, 2006August 31, 2012December 31, 2012
    CommentIndicator end target not yet achieved by August 31, 2012, but less than 1% from target for Phase I provinces (so high chance ofbeing achieved by project close for Phase I provinces).
  • Proportion of eligible children less than 18 months old with coverage of measles vaccine or triple viral.Value75%Phase I: 85.1%Phase II: 60.1%95%
    DateAugust 30, 2006August 31, 2012December 31, 2012
    CommentIndicator end target not achieved by August 31, 2012.
  • Proportion of eligible puerperal women that received at least one Sexual and Reproductive Health Care consultation.Valuen.a.Phase I: 94.2%Phase II: 89.5%60%
    DateAugust 30, 2006August 31, 2012December 31, 2012
    CommentIndicator end target achieved (and substantially surpassed) for both Phase I and II provinces.
  • Proportion of eligible children 1 year old or less, with all well child consultations up to date (percentile of weight and height).Valuen.a.Phase I: 53.4%Phase II:34.9%50%
    DateAugust 30, 2006August 31, 2012December 31, 2012
    CommentIndicator partially achieved. Indicator end target achieved for Phase I provinces but not for Phase II provinces (by August 31,2012).
  • Proportion of newborns, from eligible pregnant women, with #Apgar score higher than #6#at minuteValuen.a.Phase I: 93.2%Phase II: 93.2%92%
    DateAugust 30, 2006August 31, 2012December 31, 2012
    CommentIndicator end target achieved for both Phase I and II provinces.

INTERMEDIATE RESULTS INDICATORS

INDICATORBASELINECURRENTTARGET
  • Targeted groups increase, knowledge of their entitlements under the program and participation in Plan Nacer, and report satisfaction with process and resultsValuen/aAccording to the “Estudio de Financiamiento y Uso At least 70% of eligible population reports (in su
    DateAugust 30, 2006November 26, 2012December 31, 2012
    CommentPartially Achieved. Target achieved for Phase I provinces, but information not available for Phase II provinces at present.However, a follow-up survey is under way, covering Phase I and Phase II provinces, that will allow further data to be obtained inthe next few months on this indicator (among others).
  • Project implementation reports available as agreed, including financial reports supporting the capitation payments. Satisfactory reports from Concurrent and annual financial auditorValuen/aSatisfactory reports available in 23 out of 24 eliAt least 80% of the reports
    DateAugust 30, 2006October 31, 2011December 31, 2012
    Comment
  • Capitation payment occurring according to approved enrollment lists and trazadora systemsValue0%Capitation payment occuring in 24 out of 24 provinIn at least 9 eligible provinces in central and so
    DateAugust 30, 2006October 31, 2012December 31, 2012
    CommentThis indicator end target has been achieved, and substantially surpassed.
  • PHSPT and NHSPT function effectively according to concurrent and financial audits.Value0%NHSPT functions effectively; PHSPTs function effecIn at least 50% of all participating provinces
    DateAugust 30, 2006October 31, 2012December 31, 2012
    CommentThis indicator end target has been achieved, and substantially surpassed.Achieved
  • Number of authorized providers receiving the basic medical equipment / vehicles / communication equipment according to the annual performance agreementValue0%85.3% of authorized providersAt least 50% of those for whom an investment proje
    DateAugust 30, 2006October 31, 2012December 31, 2012
    CommentThis indicator end target has been achieved, and substantially surpassed.
  • Number of PHSPTs established and functioning, capable of preparing and negotiating MSP-MSN and MSP-authorized providers annual performance agreements.Value0%Established PHSPTs in 24 out of 24 participant proAt least 60% of all participant provinces
    DateAugust 30, 2006October 31, 2012December 31, 2012
    CommentThis indicator end target has been achieved, and substantially surpassed.Achieved
  • NHSPT is established and functioning, capable of preparing and negotiating MSN-MSP annual performance agreementsValuen/aNHSPT has been established and is operationalOne National Direction for purchase of medical ser
    DateAugust 30, 2006October 31, 2012December 31, 2012
    CommentThis indicator has been achieved.Achieved
  • Regular information process among stakeholders on maternal-child health care issues in general and entitlements in the Plan Nacer in particularValuen/aInformation campaign has been implemented in all tInformation and dissemination campaign launched at
    DateAugust 30, 2006April 30, 2011December 31, 2012
    CommentAchieved
  • Project evaluation implemented: (i) baseline at the end of PY2; mid term impact evaluation at the end of PY3; and final impact evaluation at the end of last year of APL-IValuen/aBaseline available, midterm evaluation ongoing.
    DateAugust 30, 2006November 26, 2012
    CommentPartially achieved.
  • Loan disbursementsValuen/a$293 million disbursed (98%) according to Client C100% Loan amount
    DateAugust 30, 2006November 26, 2012December 31, 2011
    CommentIndicator target almost fully achieved.